Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors

American Journal of Health-System Pharmacy

Volumn 60, Issue 13, 2003, Pages 1343-1345

  Le, Grace H ^a   Schaefer, Monica G ^a   Plowman, Brian K ^a   Morreale, Anthony P ^a   Delattre, Melissa ^a   Okino, Lisa ^a   Felicio, Leda ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; DIGOXIGENIN; DIGOXIN; DRUG METABOLITE; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; PROTON PUMP;

CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG RESEARCH; HUMAN; NOTE; PRIORITY JOURNAL; STOMACH PH; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG INTERACTION; MALE; PROSPECTIVE STUDY; PUBLICATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; BENZIMIDAZOLES; DIGOXIN; DRUG INTERACTIONS; FORMULARIES, HOSPITAL; HUMANS; MALE; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMPS;

EID: 0242336611     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.13.1343     Document Type: Note

References (8)

1. Anderson T. Pharmacokinetics, metabolism and drug interactions of proton pump inhibitors. Clin Pharmacokinet. 1996; 31(1):9-28.
2. Gerson LB, Triadafilopoulos G. Proton pump inhibitors and their drug interactions: an evidence-based approach. Eur J Gastroenterol Hepatol. 2001; 13(5):611-6.
3. Poole P. Pantoprazole. Am J Health-Syst Pharm. 2001; 58:999-1008.
4. Humphries TJ, Nardil RV, Lazar JD et al. Drug-drug interaction evaluation of rabeprazole sodium: a clean/expected slate? Gut. 1996; 39(suppl 3):A47. Abstract.
5. Humphries TJ, Merritt GJ. Review article: drug interactions with agents used to treat acid-related diseases. Aliment Pharmacol Ther. 1999; 13(suppl 3):18-26.
6. Aciphex (rabeprazole sodium) product information. Tokyo, Japan: Eisai; 1999.
7. Cohen AF, Kroon R, Schoemaker R et al. Influence of gastric acidity on the bioavailability of digoxin. Ann Intern Med. 1991; 115:540-5.
8. Oosterhuis B, Jonkman JH, Andersson T et al. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose. Br J Clin Pharmacol. 1991; 32:569-72.